Liraglutide for patients with non-alcoholic steatohepatitis

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.

GUIDELINE DEVELOPMENT Non-alcoholic steatohepatitis (NASH) is an increasing cause of liver disease necessitating liver transplantation. In patients with advanced NASH, there are often coexistent clinical issues that impact on the outcome of liver transplantation. There are no guidelines for the assessment and management of patients with NASH undergoing liver transplantation. A group was therefo...

Non-alcoholic steatohepatitis

Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis

We thank Balta et al. for their comments (1). In our study we investigated the presence of endothelial dysfunction and potential predictors of endothelial dysfunction (ED) in patients with non-alcoholic steatohepatitis (NASH) (2). We found that serum gamma glutamyl transferase (GGT) and alanine transaminase (ALT) concentrations were predictors of ED in patients with NASH. Balta et al. mention t...

Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).

BACKGROUND AND OBJECTIVES Metabolic alterations are a common feature in patients affected by non-alcoholic steato-hepatitis (NASH). A strong correlation exists between overweight, in particular visceral fat accumulation, and prevalence of NASH, especially in men. Thus, diet-induced weight loss represents a fundamental tool in disease management of these patients. The aim of the present study wa...

Endothelial dysfunction in patients with non-alcoholic steatohepatitis

Dear Editor, I read with great interest the paper by Arinc et al. (1). They investigated the presence of endothelial dysfunction in a group of patients with non-alcoholic steatohepatitis (NASH). They found that patients with NASH have impaired flow-mediated dilatation (FMD) and increased carotid artery intima-media thickness (CIMT) when compared with healthy controls. And serum concentrations o...